OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

Cardiovascular disease therapeutics via engineered oral microbiota: Applications and perspective
Wenyu Zhen, Zifei Wang, Qing Wang, et al.
iMeta (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 54

Interkingdom signaling between gastrointestinal hormones and the gut microbiome
Xinyu Zhao, Ye Qiu, Lanfan Liang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2

Influence of Bariatric Surgery on Gut Microbiota Composition and Its Implication on Brain and Peripheral Targets
Sevag Hamamah, A. Hajnal, Mihai Covașă
Nutrients (2024) Vol. 16, Iss. 7, pp. 1071-1071
Open Access | Times Cited: 10

Exploring the Significance of Gut Microbiota in Diabetes Pathogenesis and Management—A Narrative Review
Ewelina Młynarska, Jakub Wasiak, Agata Gajewska, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1938-1938
Open Access | Times Cited: 5

Multiplex genetic manipulations in Clostridium butyricum and Clostridium sporogenes to secrete recombinant antigen proteins for oral-spore vaccination
Yanchao Zhang, Tom S. Bailey, Philip Hittmeyer, et al.
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4

Hypoglycemic effect of C. butyricum -pMTL007-GLP-1 engineered probiotics on type 2 diabetes mellitus
Dexi Zhou, Shengjie Li, Gang Hu, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access

The Role and Mechanism of Gut Microbiota in the Development of Diabetic Nephropathy
梅 韩
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 215-222
Closed Access

The Functions of Major Gut Microbiota in Obesity and Type 2 Diabetes
Siman Liu, Zhipeng Tao, Mingyu Qiao, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 167-167
Open Access

Probiotics: functional food ingredients with the potential to reduce hypertension
Zouquan Chen, Wanjie Liang, Jie Liang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 10

Gut microbiota: a potential new regulator of hypertension
Yanmin Ge, Jiaxin Wang, Lincong Wu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3

Advances in synthetic biology toolboxes paving the way for mechanistic understanding and strain engineering of gut commensal Bacteroides spp. and Clostridium spp.
Yang Tan, Jing Liang, Mingchi Lai, et al.
Biotechnology Advances (2023) Vol. 69, pp. 108272-108272
Closed Access | Times Cited: 8

Individuality and generality of intratumoral microbiome in the three most prevalent gynecological malignancies: an observational study
Qin Xiao, Wen‐jie Chen, Fei Wu, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 9
Open Access | Times Cited: 2

New Insights into Chronic Pancreatitis: Potential Mechanisms Related to Probiotics
Yingyu Pan, Jianing Li, Zhengyang Fan, et al.
Microorganisms (2024) Vol. 12, Iss. 9, pp. 1760-1760
Open Access | Times Cited: 2

The potential links between human gut microbiota and cardiovascular health and disease - is there a gut-cardiovascular axis?
Cátia Almeida, J. Guilherme Gonçalves-Nobre, Diogo Alpuim Costa, et al.
Frontiers in Gastroenterology (2023) Vol. 2
Open Access | Times Cited: 6

A nuclease domain fused to the Snf2 helicase confers antiphage defence in coral‐associated Halomonas meridiana
Tianlang Liu, Xinyu Gao, Ran Chen, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 1

Peptide GLP-1 receptor agonists: From injection to oral delivery strategies
Zhiqiang Ke, Qianqian Ma, Xiaonan Ye, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116471-116471
Closed Access | Times Cited: 1

Gut microbiome and metabolome in aneurysm rat with hypertension after ginsenoside Rb1 treatment
Zhaobin Zeng, Haibin Wang, Renhui Yi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3

Genetically Engineered Probiotics and Their Potential in Therapeutic Applications
Sena Davran Bulut, Hasan Ufuk Çelebioğlu
(2024), pp. 85-97
Closed Access

Page 1

Scroll to top